| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 3.8M +70.3% | 2.2M +38.9% | 1.6M -5.3% | 1.7M -11.4% | 1.9M |
| R&D | 0 | 0 | 0 | 0 | 0 |
| SG&A | 3.7M +69.7% | 2.2M +50.6% | 1.4M -13.9% | 1.7M -9.0% | 1.8M |
| Operating Income | -3780212 -70.3% | -2219538 -38.9% | -1597834 +5.3% | -1687802 +11.4% | -1905451 |
| EBITDA | -3780212 -70.3% | -2219538 -38.9% | -1597834 +5.3% | -1687802 +11.4% | -1905451 |
| Net Income | -53963083 -277.6% | 30.4M +925.8% | -3679887 +66.1% | -10850151 -22.5% | -8856067 |
| EPS (Basic) | $-53963.08 -277.6% | $30386.92 +925.8% | $-3679.89 +66.1% | $-10850.15 -22.5% | $-8856.07 |
| EPS (Diluted) | $-53963.08 -277.6% | $30386.92 +925.8% | $-3679.89 +66.1% | $-10850.15 -22.5% | $-8856.07 |
| Shares (Diluted) | 1.0K +0.0% | 1.0K +0.0% | 1.0K +0.0% | 1.0K +0.0% | 1.0K |